Fundraising FoxQuaker BioVentures
Seed–Late Stage
Also known as Quaker Capital Management Corp
Find your way into Quaker BioVentures
Sign up to see every warm intro you have to Quaker BioVentures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Quaker BioVentures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
What they invest in
from 2 of 2 portfolio companiesAI & Machine Learning ×1Biotech ×1Healthtech ×1Medical Devices ×1Robotics ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro pathTarsa Therapeutics developed TBRIA, an oral formulation of calcitonin for treating postmenopausal osteoporosis in women more than five years post menopause when other treatments are unsuitable.
BiotechPhiladelphia, US
David Brand(Executive Officer, Director)inGregory Lumpkin(Executive Officer)
BoardRichard Kollender(Director)Martin Edwards(Director)Eric Bednarski(Director)Derek Ferguson(Director)
Co-investorsForesite CapitalMVM Life Science PartnersOxford Finance LLC
Asensus Surgical (formerly TransEnterix) develops robotic-assisted surgical systems and augmented intelligence technology, including reusable instruments, to give surgeons real-time information during procedures.
AI & Machine LearningHealthtechMedical DevicesRoboticsMorrisville, US
Anthony Fernando(Executive Officer)inTodd M. Pope(Executive Officer, Director)inJoseph P Slattery(Executive Officer)inJames J. Martin(Executive Officer)Charles J. Filipi(Executive Officer, Director)Jeffrey G. Spragens(Executive Officer, Director)
Co-investorsAisling CapitalSaints CapitalSV Health InvestorsSV Life Sciences
Fund performance · per public LP disclosures
as of Jun 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Quaker BioVentures II, L.P.LPs: North Carolina Retirement Systems, New York City Police Pension Fund, Teachers' Retirement System of the City of New York +1 more | 2007 | — | 2.4% | 1.12x | 1.11x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- What stage does Quaker BioVentures invest at?
- Quaker BioVentures invests at the Seed, Late Stage stages.
Similar investors
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.
Atomico is an international venture capital firm that invests in growth-stage technology companies across multiple geographies. The firm focuses on scaling disruptive technology businesses globally.
August Capital is a venture capital firm that invests in a small number of companies, providing hands-on support to entrepreneurs building their businesses.